Viemed Healthcare
VMD
88 hedge funds and large institutions have $109M invested in Viemed Healthcare in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 13 closing their positions.
0% more funds holding
Funds holding: 88 → 88 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
1.15% less ownership
Funds ownership: 56.42% → 55.28% (-1.1%)
6% less capital invested
Capital invested by funds: $117M → $109M (-$7.3M)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.48M |
| 2 |
FCM
Forager Capital Management
Birmingham,
Alabama
|
+$1.25M |
| 3 |
CSC
Cove Street Capital
El Segundo,
California
|
+$889K |
| 4 |
Renaissance Technologies
New York
|
+$865K |
| 5 |
D.E. Shaw & Co
New York
|
+$568K |
Top Sellers
VMD Hedge Fund Activity: Q1 2022 in Review
88 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2022, worth a combined $109M — down 6.3% from $117M a quarter earlier.
Fund positioning in VMD was balanced in Q1 2022: 13 funds opened new positions, 13 closed out, 26 added to existing stakes and 29 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $1.48M. The largest seller was Russell Investments Group, exiting entirely with an estimated $3.22M sold.
- 88 institutional investors held Viemed Healthcare (VMD) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $109M of Viemed Healthcare stock for Q1 2022, down 6.3% quarter-over-quarter.
- 13 funds opened new Viemed Healthcare positions in Q1 2022 and 13 closed out, a net change of 0 holders.
- The largest Viemed Healthcare buyer in Q1 2022 was Wasatch Advisors, an estimated $1.48M added.
- The largest Viemed Healthcare seller in Q1 2022 was Russell Investments Group, an estimated $3.22M sold.
Based on aggregated 13F filings for Q1 2022.